Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/HSA/MIOSTAT INTRAOCULAR SOLUTION 0.01%

Approved

THERAPEUTIC

MIOSTAT INTRAOCULAR SOLUTION 0.01%

ALCON RESEARCH LLC (UNITED STATES)🇸🇬 Health Sciences Authority

Approval Date: Jun 2, 1990
Approval ID: dafe831674be2ceb
Company: ALCON RESEARCH LLC (UNITED STATES)
Type: Therapeutic

Approval Details

Approval Id: dafe831674be2ceb
Drug Name: MIOSTAT INTRAOCULAR SOLUTION 0.01%
Product Name: MIOSTAT INTRAOCULAR SOLUTION 0.01%
Approval Number: SIN04572P
Approval Date: 1990-06-02
Registrant: ALCON PTE LTD
Licence Holder: ALCON PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: INJECTION
Route Of Administration: INTRAOCULAR
Atc Code: S01EB02
Atc Item Name: carbachol
Pharma Manufacturer Name: ALCON PTE LTD
Company Detail Path: /organization/alcon-pte-ltd

Active Ingredients

CARBACHOL

0.01%

CARBACHOL

0.01%

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 2, 1990

Approval ID

dafe831674be2ceb

Type

Therapeutic

Back to HSA Approvals

MIOSTAT INTRAOCULAR SOLUTION 0.01% - HSA Drug Approval Details